📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Acetylon

1.1 - Company Overview

Acetylon Logo

Acetylon

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of small molecule drugs aimed at realizing the therapeutic potential of histone deacetylase; incorporated in 2008 and based in Boston, Massachusetts.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Acetylon

Cabrellis Logo

Cabrellis

HQ: United States Website
  • Description: Provider of specialty pharmaceutical cancer therapy development, planning three small cell lung cancer clinical trials in 2006, including a study assessing the safety and efficacy of Calsed(TM) in reference to topotecan for second-line treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cabrellis company profile →
CASI Pharmaceuticals Logo

CASI Pharmaceuticals

HQ: United States Website
  • Description: Provider of business development aimed at building a pipeline through mutually beneficial transactions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CASI Pharmaceuticals company profile →
TargImmune Logo

TargImmune

HQ: Switzerland Website
  • Description: Provider of novel targeted onco-immunotherapies via its CTPIC non-viral vector platform to target and destroy receptor-overexpressing cancer cells. Offers the Ta:RNA platform using targeted nanoparticles to deliver synthetic double-stranded RNA (Poly-IC) to induce apoptosis and immune modulation. Pipeline includes TAR001 for EGFR-positive solid cancers advancing to clinical trials and TAR002 in preclinical for other solid tumor receptors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TargImmune company profile →
Intradigm Logo

Intradigm

HQ: United States Website
  • Description: Provider of RNA interference (RNAi) therapeutics for the treatment of serious diseases, with an initial focus on oncology. The private biotechnology company leverages drug development and delivery expertise as the foundation of its RNAi platform, including a proprietary RNAi Nanoplex delivery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intradigm company profile →
Aadi Bioscience Logo

Aadi Bioscience

HQ: United States Website
  • Description: Provider of a potential mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aadi Bioscience company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Acetylon

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Acetylon

2.2 - Growth funds investing in similar companies to Acetylon

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Acetylon

4.2 - Public trading comparable groups for Acetylon

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Acetylon

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Acetylon

What does Acetylon do?

Acetylon is a provider of small molecule drugs aimed at realizing the therapeutic potential of histone deacetylase; incorporated in 2008 and based in Boston, Massachusetts.

Who are Acetylon's competitors?

Acetylon's competitors and similar companies include Cabrellis, CASI Pharmaceuticals, TargImmune, Intradigm, and Aadi Bioscience.

Where is Acetylon headquartered?

Acetylon is headquartered in United States.

How many employees does Acetylon have?

Acetylon has 1,000 employees 🔒.

When was Acetylon founded?

Acetylon was founded in 2010 🔒.

What sector and industry vertical is Acetylon in?

Acetylon is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Acetylon

Who are the top strategic acquirers in Acetylon's sector and industry

Top strategic M&A buyers and acquirers in Acetylon's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Acetylon?

Top strategic M&A buyers groups and sectors for Acetylon include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Acetylon's sector and industry vertical

Which are the top PE firms investing in Acetylon's sector and industry vertical?

Top PE firms investing in Acetylon's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Acetylon's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Acetylon's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Acetylon's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Acetylon include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Acetylon's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Acetylon?

The key public trading comparables and valuation benchmarks for Acetylon include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Acetylon for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Acetylon with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Acetylon's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Acetylon with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Acetylon's' sector and industry vertical?

Access recent funding rounds and capital raises in Acetylon's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Acetylon